Search research articles
Contact Us
Filters
Showing results (61-70 of 89) with videos related to
Page
of 9
Sort By:
Biorxiv : the Preprint Server for Biology
|
September 21, 2021
Synthetic Multiantigen MVA Vaccine COH04S1 Protects Against SARS-CoV-2 in Syrian Hamsters and Non-Human Primates
Flavia Chiuppesi, Vu H Nguyen, Yoonsuh Park, et al.
NPJ Vaccines
|
January 22, 2022
Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates
Flavia Chiuppesi, Vu H Nguyen, Yoonsuh Park, et al.
Plos One
|
May 14, 2020
Correction: Lifelong aerobic exercise protects against inflammaging and cancer
Mats I Nilsson, Jacqueline M Bourgeois, Joshua P Nederveen, et al.
Nature Medicine
|
November 12, 2024
Seven-year performance of a clinical metagenomic next-generation sequencing test for diagnosis of central nervous system infections
Patrick Benoit, Noah Brazer, Mikael de Lorenzi-Tognon, et al.
Plos One
|
January 26, 2019
Lifelong aerobic exercise protects against inflammaging and cancer
Mats I Nilsson, Jacqueline M Bourgeois, Joshua P Nederveen, et al.
Nature Communications
|
December 1, 2020
Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform
Flavia Chiuppesi, Marcela d'Alincourt Salazar, Heidi Contreras, et al.
Biorxiv : the Preprint Server for Biology
|
July 9, 2020
Development of a Synthetic Poxvirus-Based SARS-CoV-2 Vaccine
Flavia Chiuppesi, Marcela d'Alincourt Salazar, Heidi Contreras, et al.
Scientific Reports
|
February 27, 2025
Virtual delivery of group-based cognitive behavioral therapy for autistic children and youth during the COVID-19 pandemic was acceptable, feasible, and effective
Jessica Brian, Abbie Solish, Jonathan Leef, et al.
The Journal of Infectious Diseases
|
September 22, 2022
Neutralizing Immunity Induced Against the Omicron BA.1 and BA.2 Variants in Vaccine Breakthrough Infections
Noah Brazer, Mary Kate Morris, Venice Servellita, et al.
Cancer Research Communications
|
February 23, 2024
The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Results from a Randomized Phase I Pilot Study for Feasibility and Adherence
Laura F Mendez Luque, Julio Avelar-Barragan, Hellen Nguyen, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 89) with videos related to
Sort By:
Page
of 9
Biorxiv : the Preprint Server for Biology
|
September 21, 2021
Synthetic Multiantigen MVA Vaccine COH04S1 Protects Against SARS-CoV-2 in Syrian Hamsters and Non-Human Primates
Flavia Chiuppesi, Vu H Nguyen, Yoonsuh Park, et al.
NPJ Vaccines
|
January 22, 2022
Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates
Flavia Chiuppesi, Vu H Nguyen, Yoonsuh Park, et al.
Plos One
|
May 14, 2020
Correction: Lifelong aerobic exercise protects against inflammaging and cancer
Mats I Nilsson, Jacqueline M Bourgeois, Joshua P Nederveen, et al.
Nature Medicine
|
November 12, 2024
Seven-year performance of a clinical metagenomic next-generation sequencing test for diagnosis of central nervous system infections
Patrick Benoit, Noah Brazer, Mikael de Lorenzi-Tognon, et al.
Plos One
|
January 26, 2019
Lifelong aerobic exercise protects against inflammaging and cancer
Mats I Nilsson, Jacqueline M Bourgeois, Joshua P Nederveen, et al.
Nature Communications
|
December 1, 2020
Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform
Flavia Chiuppesi, Marcela d'Alincourt Salazar, Heidi Contreras, et al.
Biorxiv : the Preprint Server for Biology
|
July 9, 2020
Development of a Synthetic Poxvirus-Based SARS-CoV-2 Vaccine
Flavia Chiuppesi, Marcela d'Alincourt Salazar, Heidi Contreras, et al.
Scientific Reports
|
February 27, 2025
Virtual delivery of group-based cognitive behavioral therapy for autistic children and youth during the COVID-19 pandemic was acceptable, feasible, and effective
Jessica Brian, Abbie Solish, Jonathan Leef, et al.
The Journal of Infectious Diseases
|
September 22, 2022
Neutralizing Immunity Induced Against the Omicron BA.1 and BA.2 Variants in Vaccine Breakthrough Infections
Noah Brazer, Mary Kate Morris, Venice Servellita, et al.
Cancer Research Communications
|
February 23, 2024
The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Results from a Randomized Phase I Pilot Study for Feasibility and Adherence
Laura F Mendez Luque, Julio Avelar-Barragan, Hellen Nguyen, et al.
Page
of 9